Transplant International

REMEMBER!!! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

STAY TUNED!! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

WHAT’S NEW? To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

REMEMBER! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

DID YOU DO IT? To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

DON’T FORGET! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

DON’T FORGET! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

DON’T FORGET! To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here. Stay connected! Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

📖 Read the full publication & see the visual abstract: Frontiers Publishing Partnerships | Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus Register here: go.esot.org/ti_jc17march (6/6)

🚨 Why is this important? Highly sensitized patients face longer wait times, fewer organ offers, & higher rejection risk. Imlifidase, a rapid IgG-cleaving enzyme, may change this—but clinical guidance is needed! This expert consensus aims to bridge that gap. (2/6)

📢 Join our next @Transplant International Journal Club! We’ll dive into a Delphi consensus on imlifidase for HLA-incompatible kidney transplantation in highly sensitized patients. 🏥💉 #Transplantation #KidneyTransplant (1/6) Register here: go.esot.org/ti_jc17march

To ensure we share cutting-edge research and key discussions where they matter most, we will focus on other platforms and post less frequently here. Stay connected with us: Linkedin: shorturl.at/2plxb Instagram: shorturl.at/QLhJx Bluesky: shorturl.at/IOMyF

“Evaluating Risk in Kidney Living Donors” Read more here: bit.ly/43kdH49 #risk #living #donor #kidney #transplant @ESOTtransplant @Lucreziafurian @AnkaraUni

DON’T MISS THE JANUARY ISSUE OF TRANSPLANT INTERNATIONAL Check it out here: bit.ly/3Xq1EOX @ESOTtransplant @FrontPartners #face #transplant

“Heart Transplantation and Donation After Circulatory Death in Children. A Review of the Technological, Logistical and Ethical Framework” Read more here: bit.ly/432pDY6 #heart #transplant #children #donor #circulatory @ESOTtransplant @NHS @AlexU_Edu_E @UWC_Maastricht

“Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome” Read more here: bit.ly/4i1JtHb #machine #perfusion #liver #transplant #graft #outcome @ESOTtransplant @LMU_Muenchen @MayoClinicHS